Cynata Therapeutics Limited (CYP.AX)
AUD 0.2
(11.43%)
AUD 0.2
(11.43%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 2.31 Million | 1.65 Million | 7.77 Million | 1.54 Million | 7.01 Million | 1.3 Million |
| Cost of Revenue | - | 279.96 Thousand | 279.96 Thousand | 279.96 Thousand | 280.73 Thousand | 279.96 Thousand |
| Gross Profit | 2.31 Million | 1.37 Million | 7.49 Million | 1.26 Million | 6.73 Million | 1.02 Million |
| Operating Expenses | 11.12 Million | 16.26 Million | 6.62 Million | 8.8 Million | 10.23 Million | 9.78 Million |
| Selling, General and Administrative Expenses | 2.16 Million | 3.86 Million | 4.73 Million | 5.02 Million | 4.08 Million | 4.12 Million |
| Research and Development Expenses | 8.68 Million | 12.39 Million | 8.82 Million | 3.77 Million | 5.91 Million | 5.65 Million |
| Other Expenses | - | 1.91 Million | 6.93 Million | 1.29 Million | -222.48 Thousand | 1.32 Million |
| Cost and Expenses | 11.12 Million | 16.54 Million | 6.9 Million | 9.08 Million | 10.51 Million | 10.06 Million |
| Operating Income | -8.8 Million | -16.54 Million | -6.9 Million | -9.08 Million | -10.51 Million | -10.06 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -2.31 Million | -1.65 Million | -832.67 Thousand | -1.39 Million | -2.51 Million | -1.3 Million |
| Earnings before Tax | -12.06 Million | -15.93 Million | -6.27 Million | -9.08 Million | -6.14 Million | -9.78 Million |
| Net Income | -9.74 Million | -14.27 Million | -5.44 Million | -7.68 Million | -3.63 Million | -8.47 Million |
| Earnings Per Share Basic | -0.05 | -0.10 | -0.04 | -0.06 | -0.03 | -0.08 |
| Earnings Per Share Diluted | -0.05 | -0.10 | -0.04 | -0.06 | -0.03 | -0.08 |
| Weighted Average Shares Outstanding | 179.63 Million | 145.09 Million | 143.27 Million | 130.42 Million | 104.82 Million | 100.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 179.63 Million | 145.09 Million | 143.27 Million | 130.42 Million | 104.82 Million | 100.21 Million |
| Gross Margin | 1.00 | 0.83 | 0.96 | 0.82 | 0.96 | 0.79 |
| EBIT Margin | -4.30 | -9.83 | -0.85 | -5.69 | -1.46 | -7.47 |
| Profit Margin | -4.21 | -8.63 | -0.70 | -4.97 | -0.52 | -6.47 |
| EBITDA | -9.95 Million | -15.65 Million | -5.99 Million | -8.8 Million | -5.86 Million | -9.5 Million |
| Earnings Before Tax Margin | -3.80 | -10.00 | -0.89 | -5.87 | -1.50 | -7.69 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | -230.06 Thousand | 2.54 Million | 1.65 Million | -146.69 Thousand | 1.8 Million |
| Cost of Revenue | 280.73 Thousand | 140.36 Thousand | 140.36 Thousand | 279.96 Thousand | 139.98 Thousand | 139.98 Thousand |
| Gross Profit | -280.73 Thousand | -370.43 Thousand | 2.4 Million | 1.37 Million | -286.67 Thousand | 1.66 Million |
| Operating Expenses | 12.26 Million | 12.85 Million | 6.94 Million | 16.26 Million | 9.17 Million | 6.83 Million |
| Selling, General and Administrative Expenses | - | 3.89 Million | 6.94 Million | - | 9.17 Million | 6.83 Million |
| Research and Development Expenses | - | 8.96 Million | - | - | 12.67 Million | - |
| Other Expenses | - | - | - | 1.91 Million | - | - |
| Cost and Expenses | 12.54 Million | 12.85 Million | 7.08 Million | 16.54 Million | 9.31 Million | 6.97 Million |
| Operating Income | -12.54 Million | -13.08 Million | -7.08 Million | -16.54 Million | -9.31 Million | -6.97 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -2.31 Million | 4.00 | -2.31 Million | -1.65 Million | -2.00 | -1.65 Million |
| Earnings before Tax | -12.06 Million | -5.2 Million | -6.85 Million | -15.93 Million | -9.1 Million | -6.82 Million |
| Net Income | -9.74 Million | -5.2 Million | -4.54 Million | -14.27 Million | -9.1 Million | -5.17 Million |
| Earnings Per Share Basic | - | -0.03 | -0.03 | - | -0.06 | -0.04 |
| Earnings Per Share Diluted | - | -0.03 | -0.03 | - | -0.06 | -0.04 |
| Weighted Average Shares Outstanding | 179.63 Million | 179.77 Million | 179.63 Million | 145.09 Million | 146.14 Million | 143.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 179.63 Million | 179.77 Million | 179.63 Million | 145.09 Million | 146.14 Million | 143.27 Million |
| Gross Margin | - | 1.61 | 0.94 | 0.83 | 1.95 | 0.92 |
| EBIT Margin | - | 24.12 | -2.73 | - | 62.52 | -3.79 |
| Profit Margin | - | 22.62 | -1.78 | -8.63 | 62.06 | -2.87 |
| EBITDA | - | -5.54 Million | -6.94 Million | - | -9.17 Million | -6.83 Million |
| Earnings Before Tax Margin | - | 56.87 | -2.78 | -10.00 | 63.47 | -3.87 |
MONET
MBH
5856
GAM
MUV2
3CP